retatrutide clinical trials efficacy (RETA) is one of the most promising investigational peptides in obesity research— Lilly's retatrutide shows 28% weight

Retatrutide is made of a specific sequence of amino acids arranged into a synthetic peptide chain

Interestingly, participants receiving GLP-1 RA therapy demonstrated an increase in weight compared with the SGLT2i group

Until the FDA reviews the full evidence and approves retatrutide, it wont be legally available as a prescription drug and wont have an official dose, price, or label

20 High-calorie diets Overconsumption of sugar-sweetened beverages containing sucrose or high-fructose corn syrup is associated with increased visceral fat, fatty liver, and steatohepatitis

President Trump announced a new deal this week with drugmakers Eli Lilly and Novo Nordisk, aimed at expanding coverage and lowering prices for GLP-1 medications